ANGPT2 and retinal disorder: Beyond its anti-VEGF activity, aflibercept has been shown clinically and experimentally to modulate additional factors, such as PlGF,26 galectin-1,27 and ANG2, and effects such as retinal inflammation in an oxygen-induced retinopathy model in mice.2